Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
about
Polypoidal Choroidal Vasculopathy in AsiansPolypoidal choroidal vasculopathy: an update on therapeutic approachesMeta-analysis of best corrected visual acuity after treatment for myopic choroidal neovascularisation.Automatic Segmentation of Polypoidal Choroidal Vasculopathy from Indocyanine Green Angiography Using Spatial and Temporal Patterns.Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy.Verteporfin photodynamic therapy combined with intravitreal ranibizumab for polypoidal choroidal vasculopathy controversy concerning long-term followup.Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia.Baseline polyp size as a potential predictive factor for recurrence of polypoidal choroidal vasculopathy.Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.Two-year results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports
P2860
Q26799548-4A1C0B7A-6E3D-48E2-AB51-060692E1A719Q27006758-3D34EA14-48B2-49E2-9748-D574E4FC2C90Q34063100-523B0731-E949-4B3D-B0DC-F10F8493373AQ35190854-57CD9596-F9C9-4D05-BA23-EBC75231BB12Q37087140-A3305D54-C542-4B8E-831B-5961C8956677Q37168836-DF97A985-6399-43B7-A52B-ED4B892C7498Q41627130-153F2012-84C4-4129-80FC-86F309E16CA4Q41763938-36C6925D-6487-48C4-979D-EF4F2EA9EA66Q47139871-B869C7C1-6143-4F66-944D-88660A828B9EQ47338796-2F22C7DB-FD08-4454-B781-47DF6FC25023Q47852586-F8E84B40-6797-40C1-A8B9-C6EA59DCACD8Q50452433-37D9F88B-2183-4155-A4FD-A713CB27D1FAQ50482167-3F9402DF-668E-425A-A820-F580008469C6Q50513031-2905A074-8016-4AAD-BC83-D9F228968BD4Q58613700-DFA8C0CC-7046-4A88-ABB2-3E00B8C9E8FB
P2860
Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Photodynamic therapy with vert ...... ts after 3 years of follow-up.
@en
Photodynamic therapy with vert ...... ts after 3 years of follow-up.
@nl
type
label
Photodynamic therapy with vert ...... ts after 3 years of follow-up.
@en
Photodynamic therapy with vert ...... ts after 3 years of follow-up.
@nl
prefLabel
Photodynamic therapy with vert ...... ts after 3 years of follow-up.
@en
Photodynamic therapy with vert ...... ts after 3 years of follow-up.
@nl
P2093
P50
P1433
P1476
Photodynamic therapy with vert ...... lts after 3 years of follow-up
@en
P2093
Isabel Pires
José Rui Faria de Abreu
Sérgio Leal
P304
P356
10.1097/IAE.0B013E3181D37486
P577
2010-09-01T00:00:00Z